Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;50(5):376-9.
doi: 10.1310/hpj5005-376.

Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam

Jennifer Wade  1 , Mandelin Cooper  1 , Robert Ragan  1
Affiliations

Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam

Jennifer Wade et al. Hosp Pharm. 2015 May.

Abstract

Purpose: To evaluate the physical compatibility of vancomycin with piperacillin-tazobactam during simulated Y-site administration.

Methods: Vancomycin and piperacillin-tazobactam were tested using 2 different diluents: 0.9% sodium chloride and 5% dextrose for injection. Vancomycin concentrations of 2, 5, and 10 mg/mL were tested using 0.9% sodium chloride and 4 and 8 mg/mL in 5% dextrose. Piperacillin-tazobactam was diluted to 16, 30, 40, 80, and 100 mg/mL, representing common concentrations used clinically in hospitals, and concentrations were tested in both 0.9% sodium chloride and 5% dextrose for injection. Medications were reconstituted under USP <797> aseptic technique. Combinations were tested in duplicate and reverse order with control solutions. Compatibility testing for Y-site included visual inspection, inspection with a high-intensity monodirectional light source (Tyndall beam), turbidimeter for turbidity evaluation, pH, and microscopic viewing. Testing occurred immediately after mixing, 15 minutes, 60 minutes, and 4 hours. If inconsistencies were observed between samples, testing was repeated to confirm results. Solutions were deemed incompatible if any one test failed and compatible if all tests were accepted.

Results: When dextrose 5% for injection was used as the diluent, vancomycin 4 mg/mL was Y-site compatible with piperacillin-tazobactam 16, 30, and 40 mg/mL and incompatible with 80 and 100 mg/mL. Vancomycin 8 mg/mL was incompatible with all tested concentrations of piperacillin-tazobactam. When 0.9% sodium chloride was used as the diluents, Y-site compatibility was found with vancomycin 2 and 5 mg/mL and all tested concentrations of piperacillin-tazobactam. Vancomycin 10 mg/mL was incompatible with piperacillin-tazobactam 40, 80, and 100 mg/mL. Incompatibilities formed a white precipitate immediately on mixing.

Conclusion: Y-site incompatibility was greater for the tested concentrations of piperacillin-tazobactam and vancomycin when 5% dextrose was used as the diluent versus 0.9% sodium chloride. Y-site incompatibility was seen immediately in the form of a white precipitate on mixing.

Keywords: Y-site; Zosyn; compatibility; piperacillin-tazobactam; vancomycin.

PubMed Disclaimer

References

    1. McEvoy GK, ed. AHFS Drug Information: Vancomycin Hydrochloride. 13th ed. Bethesda, MD: American Society of Health System Pharmacists; 2013:433–449.
    1. McEvoy GK, ed. AHFS Drug Information: Piperacillin Sodium and Tazobactam Sodium. 13th ed. Bethesda, MD: American Society of Health System Pharmacists; 2013:313–317.
    1. Yost RJ, Cappelletty DM.The retrospective cohort of extended-infusion piperacillin-tazobactam (RECEIPT) study: A multicenter study. Pharmacotherapy. 2011;37:767–775. - PubMed
    1. Lodise TP, Lomaestro B, Drusano GL.Piperacillin-tazobactam for pseudomonas aeruginosa infection: Clinical implications of an extended-infusion dosing strategy. Clin Infect Dis. 2007;44:357–363. - PubMed
    1. Trissel LA, Martinez JF.Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Am J Hosp Pharm. 1994;51:672–678. - PubMed

LinkOut - more resources